ETV 1/ TGF ‐β/ SMAD 4‐ CTGF Axis Activated Tumor‐ CAFs Crosstalk Promotes Poor Progression in Hepatocellular Carcinoma Patients
Cancer Medicine · 2026-08 · 15 (8)
DOI: 10.1002/cam4.72180 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 21.08.2026. Verfasst von Tongwang Yang und 3 weiteren Autor:innen. Beteiligte Einrichtung: The Hunan Provincial University Key Laboratory of the Fundamental and Clinical Research on Functional Nucleic Acid, Changsha Medical University, Chan…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Connective Tissue Growth Factor, Transforming Growth Factor beta. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hunan Province, Education Department of Hunan Province.
Abstract (Originalsprache)
The transcription factor ETV1 plays a critical oncogenic role in tumors; its function in cancer‐associated fibroblasts (CAFs) remains poorly understood. We identified a positive correlation between ETV1 and CAFs infiltration in TIMER2.0, and overexpressed ETV1 predicted a poor prognosis in patients from TCGA. Consistently, ETV1 positively correlated with markers of CAFs. α‐SMA, PDGFRβ, TGF‐β, COL1A1, and CTGF, markers of CAFs, were downregulated in LI90 cells cocultured with ETV1 low‐expressed Huh7 cells, and CTGF presented the most pronounced reduction. Though no direct ETV1 binding domains were predicted in the CTGF promoter, ETV1 activates TGF‐β signaling in tumor tissues from TCGA. Intriguingly, multiple SMAD4 binding domains were predicted in the promoter of CTGF. Luciferase reporter assays, ChIP‐PCR, and EMSA presented that SMAD4 binds specifically to the P3 domain in CTGF promoter, which activated the transcription of CTGF. Rescue experiments indicated that ETV1 induced CTGF expression for the TGF‐β/SMAD4 pathway in ETV1‐shRNA‐Lv infected Huh7 cells cocultured with LI90 cells infected with SMAD4‐oe‐Lv. In humanized immune‐reconstituted mouse models, low expression of ETV1 inhibited tumor growth and CTGF expression. Moreover, DEN‐induced murine hepatocellular carcinoma tissues exhibited elevated expression of ETV1, CTGF, PCNA, and Ki67. Clinically, ETV1 was overexpressed in tumor tissues and predicted poor progression in HCC patients. Thus, our findings reveal a novel ETV1/TGF/β/SMAD‐CTGF signaling axis within the tumor microenvironment that facilitates tumor‐CAFs communication, ultimately promoting aggressive HCC progression through enhanced tumor cell proliferation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Hunan Provincial University Key Laboratory of the Fundamental and Clinical Research on Functional Nucleic Acid, Changsha Medical University, Changsha, China.
- Lishui People's Hospital, Lishui, Zhejiang, P.R. China.
- The Hunan Provincial College of Clinical Laboratory, Changsha Medical University, Changsha, P.R. China.
ORCID-Profile: Hongde Li
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Hunan Province
- Education Department of Hunan Province
- Health Commission of Hunan Province
Zitieren
APA
Yang, T., Pang, Y., Zhou, J., & Li, H. (2026). ETV 1/ TGF ‐β/ SMAD 4‐ CTGF Axis Activated Tumor‐ CAFs Crosstalk Promotes Poor Progression in Hepatocellular Carcinoma Patients. Cancer Medicine, 15(8). https://doi.org/10.1002/cam4.72180
Vancouver
Yang T, Pang Y, Zhou J, Li H. ETV 1/ TGF ‐β/ SMAD 4‐ CTGF Axis Activated Tumor‐ CAFs Crosstalk Promotes Poor Progression in Hepatocellular Carcinoma Patients. Cancer Medicine. 2026;15(8). doi:10.1002/cam4.72180
BibTeX
@article{Yang2026,
author = {Yang, Tongwang and Pang, Yiqiang and Zhou, Jiang and Li, Hongde},
title = {ETV 1/ TGF ‐β/ SMAD 4‐ CTGF Axis Activated Tumor‐ CAFs Crosstalk Promotes Poor Progression in Hepatocellular Carcinoma Patients},
journal = {Cancer Medicine},
year = {2026},
volume = {15},
number = {8},
doi = {10.1002/cam4.72180}
}
EUVIMED